| Detected | Trial | Change |
|---|---|---|
| 2026-06-03 | NCT07481708 A Clinical Study of the Effect of Enlicitide (MK-0616) Formulations in Healthy… |
Trial completed |
| 2026-05-29 | NCT07300280 A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039) |
overall status: "Active Not Recruiting" → "Recruiting" |
| 2026-05-29 | NCT07300280 A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039) |
date change Primary completion pushed: 2026-07-15 -> 2026-10-07 |
| 2026-05-29 | NCT07300280 A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039) |
date change Completion pushed: 2026-07-22 -> 2026-10-14 |
| 2026-05-23 | NCT07058077 A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and… |
Trial sites expanded: 26 -> 29 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-02 | NCT07619443 A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003) | Phase 1 | Not Yet Recruiting |
| 2026-05-29 | NCT07614984 A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a)… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07216482 | A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037) | Hyperlipidemia | Recruiting |
| NCT06008756 | Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study… | Arteriosclerosis | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT07058077 | A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and… | Heterozygous Familial Hypercholesterolemia (HeFH) | Recruiting |
| Phase 2 | |||
| NCT07614984 | A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a)… | Lipoprotein(a) | Not Yet Recruiting |
| Phase 1 | |||
| NCT07300280 | A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039) | Healthy | Recruiting |
| NCT07619443 | A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003) | Healthy | Not Yet Recruiting |